OVN — Oventus Medical Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMicro Cap
2017 June 30th | 2018 June 30th | C2019 June 30th | 2020 June 30th | 2021 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.537 | 0.271 | 0.332 | 0.419 | 1.09 |
Cost of Revenue | |||||
Gross Profit | -0.046 | 0.094 | 0.174 | 0.188 | 0.402 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.1 | 6.42 | 8.49 | 10.7 | 11 |
Operating Profit | -6.56 | -6.15 | -8.15 | -10.2 | -9.96 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.091 | -0.058 | -0.074 | -0.078 | -0.061 |
Dividends per Share |